Independent register of U.S. FDA drug recalls · updated Oct 13, 2026
RxRecalls Get alerts

FDA Drug Recalls

11,818 recalls · Class II, newest first

Class II · Moderate risk

Clopidogrel Tablets

Failed dissolution specification -Two additional lots being recalled due to Out-of-Specification results observed for dissolution at 18th month stability testing.

Terminated Dissolution failure Dr. Reddy's Laboratories, Inc. NDC 55111-671-31 D-0294-2019
Class II · Moderate risk

Estradiol Tablets

Presence of foreign tablet/capsule: A single foreign tablet was found in pharmacy dispensed bottle of 30 Estradiol 2 mg tablets.

Terminated Particulate / foreign matter Epic Pharma, LLC NDC 42806-089-01 D-0297-2019
Class II · Moderate risk

Infants' Ibuprofen

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Terminated Wrong potency / content Tris Pharma Inc. NDC 55319-250-23 D-0336-2019
Class II · Moderate risk

infants* IBUPROFEN

Superpotent Drug: recalled lots may have higher concentration of ibuprofen.

Terminated Wrong potency / content Tris Pharma Inc. NDC 49035-125-23 D-0335-2019

Recalls by year